Safety and efficacy of inhaled interferon-β1a (SNG001) in adults with mild-to-moderate COVID-19: a randomized, controlled, phase II trial
Prasanna Jagannathan, Kara W Chew, Mark J Giganti, Michael D. Hughes et autres
us, gb (code pays fourni par la source)